Have you ever wanted to try porn in virtual reality? Secretly, we all have, and Pornhub just made it insanely easy. The world’s biggest adult site partnered with established VR porn store BaDoink to offer free 360-degree content. It is obviously NFSW.
If you’ve never tried VR porn, let me tell you: It is a weird, wild ride. I tested out the new site using both iOS and Android setups and a couple different headsets. The video I saw was not exactly virtual reality as the footage wasn’t entirely 3D. Pornhub does say that the new channel will have lots of full 360-degree content, so you really feel like you’re in some San Bernardino McMansion having sex with a stranger.
Feel might be the wrong word. It certainly looks like you’re there, though the resolution on the demo video that I saw was blurry at best. At worst, Continue reading →
Spanish popular erotica embraces foreign technology and its inventions to an extent rarely seen in high cultural art and literature. It “imports” modernity in the form of techno-erotic artifacts such as bicycles and typewriters. It also engages modernity and its commodities in an intense and often ambivalent dialogue with tradition and with the production of stereotypically Spanish cultural objects: Spanish majas wearing traditional peinetas made-in-Spain enhance their legs with imported French stockings; dark Continue reading →
Saintclair’s illustrations are dramatizations of contemporary sexuality; caricatures of unexplored visual impulses. Her fine ink strokes give personality and texture to nonexistent humans in suggestive poses. Continue reading →
In the wide world of dating, there are many options. Do you go for the flashy guy with the smooth smile, or the dude in the corner typing away on his laptop? The following are reasons why I think my fellow females should pay more attention to the quiet geeks and nerds, and less attention to the flashy boys.
1.) Sex. Yep. Sex. I’m not really familiar with this myself, Continue reading →
Sprout Pharmaceuticals, Inc. (Sprout) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of Addyi™ (flibanserin 100 mg) (pronounced add-ee), a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive Continue reading →